Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
Summary: Antiviral treatments targeting the coronavirus disease 2019 are urgently required.We screened a panel of already approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and identified two new agents having higher antiviral potentials than the drug candidates such as remdesivir and wac 4011 chr